Haffner retiring from FDA to join Amgen

The FDA's director of orphan products development for the past 19 years, Marlene Haffner, will retire in January to join the biotech firm Amgen as director of its government affairs office in Washington.

James G. Dickinson

December 1, 2006

5:00 am

The FDA’s director of orphan products development for the past 19 years, Marlene Haffner, will retire in January to join the biotech firm Amgen as director of its government affairs office in Washington.

From the December 01, 2006 Issue of MM+M - Medical Marketing and Media

From Our Partners

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.